智通财经网·2025-09-15 09:24Core Viewpoint - The company received a regulatory attention letter from the Dalian Regulatory Bureau of the China Securities Regulatory Commission, highlighting insufficient impairment provisions for the Jinzhai Jiayue Phase I project and internal control deficiencies [1] Summary by Relevant Sections Impairment Issues - The company was found to have inadequately recognized impairment for the Jinzhai Jiayue Phase I project, with a reported impairment of 218 million yuan as per an assessment by Chongqing Henghe Asset Appraisal Co., Ltd. This impairment primarily concerns P-type equipment, while general equipment was not subjected to impairment [1] Internal Control Deficiencies - The Dalian Regulatory Bureau noted that the company's internal control systems were not properly executed. Issues included the lack of approval for certain procurement, loan contracts, and external guarantees. Additionally, there were instances of labor dispatch employees receiving wages on behalf of others or for severance payments [1] Board Meeting and Agreements - On May 3, 2023, the company held its sixth board meeting, where it approved a targeted issuance proposal and signed an investment agreement for a high-efficiency photovoltaic cell project with the Tongling Shizishan High-tech Zone Management Committee. These matters were not registered for insider information [1]